BioWorld-International-2007-02-07
Push By AstraZeneca Includes COPD Deal Worth Up To $500M
Push By AstraZeneca Includes COPD Deal Worth Up To $500M
LONDON - AstraZeneca plc went through a hyperactive round last week of licensing and acquisitions, sealing deals worth $650 million. (BioWorld International)

